Articles by Disease (Waldenstrom's Macroglobulinemia)

Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 15
Page: 272-292
Author(s): Romeo G. Mihăilă*

Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20
Page: 1158-1172
Author(s): Anshul Kumar, Rohit Bhatia, Pooja Chawla , Durgadas Anghore , Vipin Saini and Ravindra K. Rawal *

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16
Page: 669-688
Author(s): Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak

Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94

Journal: Current Topics in Medicinal Chemistry
Volume: 16
Page: 2765-2778
Author(s): Ephraim A. Ansa-Addo, Jessica Thaxton, Feng Hong, Bill X. Wu, Yongliang Zhang, Caroline W. Fugle, Alessandra Metelli, Brian Riesenberg, Katelyn Williams, Daniel T. Gewirth, Gabriela Chiosis, Bei Liu and Zihai Li

Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!

Journal: Current Respiratory Medicine Reviews
Volume: 12
Page: 157-166
Author(s): Wael El-Melouk and Abdul Rahman Jazieh

Epigenetic MicroRNA Regulation of Multiple Chromatin Functions: A Perspective in Cancer

Journal: Epigenetic Diagnosis & Therapy (Discontinued)
Volume: 1
Page: 81-90
Author(s): Dipta Sengupta, Moonmoon Deb, Swayamsiddha Kar, Arunima Shilpi, Sabnam Parbin, Bibekanand Mallick and Samir Kumar Patra

Natural and Induced Antibody Polyreactivity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15
Page: 1230-1241
Author(s): Annaelle Jarossay, Maya Hadzhieva, Srinivas V. Kaveri, Sebastien Lacroix-Desmazes and Jordan D. Dimitrov

Serum of Blood Separation by Means of Dynamic Electrochromatography in a Centrifugal and Electromagnetic Gradient

Journal: Recent Patents on Biotechnology
Volume: 8
Page: 215-230
Author(s): Andrzej Jan Dyszkiewicz

MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies

Journal: Current Cancer Drug Targets
Volume: 15
Page: 53-70
Author(s): Xin Li, Xin A. Zhang, Wei Xie, Xiaoqing Li and Shiang Huang

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

Journal: Current Cancer Drug Targets
Volume: 14
Page: 517-536
Author(s): Q. Ping Dou and Jeffrey A. Zonder